✓
Open
16 Aug 2011
✓
Close
18 Aug 2011
3
Allotment
—
✓
Listing
Mon, Sep 5, 2011
Price Band
₹90 to ₹100
Issue Size
63,00,000 shares (agg. up to ₹63 Cr)
Lot Size
60 Shares
Listing Date
Mon, Sep 5, 2011
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.77x |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Land | 6.35 |
| 2 | Building Construction | 12.20 |
| 3 | Plant & Machinery | 19.94 |
| 4 | Utilities | 11.00 |
| 5 | Misc. Fixed Assets | 2.30 |
| 6 | Long term working capital | 5.00 |
| 7 | General corporate purposes | 3.28 |
| 8 | Issue Expenses | 2.92 |
| Total | 62.99 |
About Brooks Laboratories IPO
Incorporated in 2002, Brooks Laboratories Ltd is in the business of Pharmaceutical Contract Research & Manufacturing. Company manufactures wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.Brooks Labs has manufacturing unit at Baddi, Himachal Pradesh. Company has a world class team to develop new molecules in injectables and clavulanic acid based products supported by sophisticated infrastructure for Research & Development. Brooks Labs is WHO-GMP and ISO 9000-2008 certified company.The Indian pharmaceuticals industry is significantly developed in terms of infrastructure, technology and product range in recent years. The country now ranks among the top four worldwide accounting for 8% to 10% of world’s production by volume and 1.5% to 2% by value.+ Read More
Contact Details
Brooks Laboratories Ltd. AddressG-101, Ivory TowerSector 70, MohaliMohali, Punjab, 160055+ (91 172) 509 7355cs@brookslabs.netVisit Website